Jefferies Upgrades Mesoblast to Buy
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst David Stanton has upgraded Mesoblast (NASDAQ:MESO) from Hold to Buy, indicating a positive outlook on the company's stock.
August 29, 2024 | 3:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst David Stanton has upgraded Mesoblast from Hold to Buy, suggesting a positive short-term outlook for the stock.
The upgrade from Hold to Buy by a reputable analyst at Jefferies is likely to boost investor confidence and attract more buyers, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100